Trametinib With GSK2141795 in BRAF Wild-type Melanoma

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborator:

National Comprehensive Cancer Network

Information provided by (Responsible Party):

Adil Daud, University of California, San Francisco

ClinicalTrials.gov Identifier:

NCT01941927

First received: August 30, 2013

Last updated: February 17, 2015

Last verified: February 2015

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	May 2016
Primary Completion Date:	December 2014 (Final data collection date for primary outcome measure)